Eli Lilly Achieves Breakthrough! The Experimental GLP-1 Pill Aided Diabetics in Weight Loss and Also Reduced Their Blood Sugar Levels

The pharmaceutical manufacturer Eli Lilly announced on April 17, 2025, that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and lowered their A1C levels. Lilly, the maker of the injectable drugs Zepbound for the treatment of obesity as well as Mounjaro and Trulicity for diabetes treatment, is one of several companies researching an effective pill form of GLP-1. The only available pill of this kind to date is associated with strict dietary...